US Physical Therapy Inc (USPH) is a publicly traded Healthcare sector company. As of May 21, 2026, USPH trades at $62.16 with a market cap of $989.83M and a P/E ratio of 121.46. USPH moved +0.99% today. Year to date, USPH is -26.12%; over the trailing twelve months it is -21.61%. Its 52-week range spans $58.19 to $101.20. Analyst consensus is strong buy with an average price target of $97.50. Rallies surfaces USPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
U.S. Physical Therapy Secures $450M Five-Year Credit Facility with Extended Maturity: U.S. Physical Therapy closed a $450 million five-year credit facility, comprising a $175 million term loan and a $275 million revolver maturing April 14, 2031. The facility, upsized from $400 million and replacing a $325 million credit line due June 17, 2027, features improved pricing and extended maturity.
| Metric | Value |
|---|---|
| Price | $62.16 |
| Market Cap | $989.83M |
| P/E Ratio | 121.46 |
| EPS | $0.51 |
| Dividend Yield | 0.46% |
| 52-Week High | $101.20 |
| 52-Week Low | $58.19 |
| Volume | 184.99K |
| Avg Volume | 0 |
| Revenue (TTM) | $795.49M |
| Net Income | $52.69M |
| Gross Margin | 19.03% |
6 analysts cover USPH: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.50.